{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:01:10Z","timestamp":1794693670279,"version":"4.9.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016064","name":"Stichting Stoffels-Hornstra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Neutrophil and eosinophil activation and its relation to disease severity has been understudied in primary care patients with COVID-19. In this study, we investigated whether the neutrophil and eosinophil compartment were affected in primary care patients with COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>COVID-19 patients, aged \u2265 40 years with cardiovascular comorbidity presenting to the general practitioner with substantial symptoms, partaking in the COVIDSat@Home study between January and April 2021, were included. Blood was drawn during and 3 to 6 months after active COVID-19 disease and analyzed by automated flow cytometry, before and after stimulation with a formyl-peptide (fNLF). Mature neutrophil and eosinophil markers at both time points were compared to healthy controls. A questionnaire was conducted on disease symptoms during and 3 to 6 months after COVID-19 disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The blood of 18 COVID-19 patients and 34 healthy controls was analyzed. During active COVID-19 disease, neutrophils showed reduced CD10 (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0360), increased CD11b (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0002) and decreased CD62L expression (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001) compared to healthy controls. During active COVID-19 disease, fNLF stimulated neutrophils showed decreased CD10 levels (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001). Three to six months after COVID-19 disease, unstimulated neutrophils showed lowered CD62L expression (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0003) and stimulated neutrophils had decreased CD10 expression (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0483) compared to healthy controls. Both (un)stimulated CD10 levels increased 3 to 6 months after active disease (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0120 and\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001, respectively) compared to during active disease. Eosinophil blood counts were reduced during active COVID-19 disease and increased 3 to 6 months after infection (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001). During active COVID-19, eosinophils showed increased unstimulated CD11b (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0139) and decreased (un)stimulated CD62L expression (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0036 and\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0156, respectively) compared to healthy controls. Three to six months after COVID-19 disease, (un)stimulated eosinophil CD62L expression was decreased (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0148 and\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0063, respectively) and the percentage of CD11b\n                      <jats:sup>bright<\/jats:sup>\n                      cells was increased (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0083 and\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0307, respectively) compared to healthy controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Automated flow cytometry analysis reveals specific mature neutrophil and eosinophil activation patterns in primary care patients with COVID-19 disease, during and 3 to 6 months after active disease. This suggests that the neutrophil and eosinophil compartment are long-term affected by COVID-19 in primary care patients. This indicates that these compartments may be involved in the pathogenesis of long COVID.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/falgy.2022.942699","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:46:33Z","timestamp":1658882793000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Neutrophil and Eosinophil Responses Remain Abnormal for Several Months in Primary Care Patients With COVID-19 Disease"],"prefix":"10.3389","volume":"3","author":[{"given":"B. N.","family":"Jukema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T. E.","family":"Hopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C. W. G.","family":"Bongers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. C.","family":"Pelgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Rijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. N.","family":"Platteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Venekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L. M.","family":"Zwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. H.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Koenderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jmii.2020.05.001","article-title":"A systematic review of asymptomatic infections with COVID-19","volume":"54","author":"Gao","year":"2021","journal-title":"J Microbiol Immunol Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mayocp.2020.10.022","article-title":"Clinical characteristics, treatment, and outcomes of critically ill patients with COVID-19: a scoping review","volume":"96","author":"Huang","year":"2021","journal-title":"Mayo Clin Proc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","article-title":"Long COVID: an overview","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/JLB.5COVA0820-520RRR","article-title":"Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation: a normal response to an abnormal situation","volume":"109","author":"Spijkerman","year":"2021","journal-title":"J Leukoc Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"107233","DOI":"10.1016\/j.intimp.2020.107233","article-title":"Neutrophils and COVID-19: The road so far","volume":"90","author":"Cavalcante-Silva","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"652470","DOI":"10.3389\/fimmu.2021.652470","article-title":"Neutrophils in COVID-19","volume":"12","author":"Reusch","year":"2021","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e20201129","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.7556\/jaoa.2020.091","article-title":"Eosinopenia and COVID-19","volume":"120","author":"Tanni","year":"2020","journal-title":"J Am Osteopath Assoc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/cells10051109","article-title":"The systemic immune response in COVID-19 is associated with a shift to formyl-peptide unresponsive eosinophils","volume":"10","author":"Koenderman","year":"2021","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12445-021-1070-x","article-title":"Nieuw onderzoek naar thuis zuurstofsaturatie meten bij COVID-19-pati\u00ebnten","volume":"64","author":"Smit","year":"2021","journal-title":"Huisarts Wet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"112646","DOI":"10.1016\/j.jim.2019.112646","article-title":"Automated flow cytometry enables high performance point-of-care analysis of leukocyte phenotypes","volume":"474","author":"Spijkerman","year":"2019","journal-title":"J Immunol Methods."},{"key":"B12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fimmu.2019.00346","article-title":"Neutrophil heterogeneity as therapeutic opportunity in immune-mediated disease","volume":"10","author":"Grieshaber-Bouyer","year":"2019","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1526-0968.2000.00191.x","article-title":"Neutrophil activation in immunoadsorption","volume":"4","author":"Ota","year":"2000","journal-title":"Ther Apher."},{"key":"B14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit Care."},{"key":"B15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: The major cell entry receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung."},{"key":"B16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/bcmd.2002.0513","article-title":"Surface antigen changes during normal neutrophilic development: a critical review","volume":"28","author":"Elghetany","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"B17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4049\/jimmunol.137.3.1075","article-title":"Structure\/function studies of the common acute lymphoblastic leukemia antigen (CALLA\/CD10) expressed on human neutrophils","volume":"137","author":"McCormack","year":"1986","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1084\/jem.157.3.1064","article-title":"Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen","volume":"157","author":"Cossman","year":"1983","journal-title":"J Exp Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1189\/jlb.1212619","article-title":"Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: correlation with transcriptome profiling of neutrophil precursors","volume":"94","author":"R\u00f8rvig","year":"2013","journal-title":"J Leukoc Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1073\/pnas.93.13.6454","article-title":"Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells","volume":"93","author":"Le Cabec","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood.V85.3.812.bloodjournal853812","article-title":"Biosynthesis of granule proteins in normal human bone marrow cells. gelatinase is a marker of terminal neutrophil differentiation","volume":"85","author":"Borregaard","year":"1995","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/imr.12440","article-title":"Granulopoiesis and granules of human neutrophils","volume":"273","author":"Cowland","year":"2016","journal-title":"Immunol Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1074\/mcp.M500143-MCP200","article-title":"Proteomic analysis of human neutrophil granules","volume":"4","author":"Lominadze","year":"2005","journal-title":"Mol Cell Proteomics."},{"key":"B24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/qjmed\/hcaa259","article-title":"an early, effective and relevant COVID-19 biomarker?","volume":"114","author":"Roca","year":"2021","journal-title":"QJM."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e14047","DOI":"10.1111\/ijcp.14047","article-title":"Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia","volume":"75","author":"Cazzaniga","year":"2021","journal-title":"Int J Clin Pract."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2109123118","DOI":"10.1073\/pnas.2109123118","article-title":"High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19","volume":"118","author":"Lourda","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1172\/JCI85664","article-title":"Lung-resident eosinophils represent a distinct regulatory eosinophil subset","volume":"126","author":"Mesnil","year":"2016","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"100078","DOI":"10.1016\/j.xcrm.2020.100078","article-title":"Systems-level immunomonitoring from acute to recovery phase of severe COVID-19","volume":"1","author":"Rodriguez","year":"2020","journal-title":"Cell reports Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1128\/iai.53.1.192-198.1986","article-title":"Bactericidal action of eosinophils from normal human blood","volume":"53","author":"Yazdanbakhsh","year":"1986","journal-title":"Infect Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1189\/jlb.70.5.691","article-title":"Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens","volume":"70","author":"Rosenberg","year":"2001","journal-title":"J Leukoc Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/vim.2018.0150","article-title":"Eosinophils and respiratory viruses","volume":"32","author":"Flores-Torres","year":"2019","journal-title":"Viral Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0158","DOI":"10.1097\/CCE.0000000000000158","article-title":"Point-of-care analysis of neutrophil phenotypes: a first step toward immuno-based precision medicine in the trauma ICU","volume":"2","author":"Spijkerman","year":"2020","journal-title":"Crit care Explor."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0206175","DOI":"10.1371\/journal.pone.0206175","article-title":"Multi-dimensional flow cytometry analysis reveals increasing changes in the systemic neutrophil compartment during seven consecutive days of endurance exercise","volume":"13","author":"van Staveren","year":"2018","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"674079","DOI":"10.3389\/fimmu.2021.674079","article-title":"Kinetics of neutrophil subsets in acute, subacute, and chronic inflammation","volume":"12","author":"Bongers","year":"2021","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1182\/blood-2016-07-727669","article-title":"Human CD62Ldim neutrophils identified as a separate subset by proteome profiling and in vivo pulse-chase labeling","volume":"129","author":"Tak","year":"2017","journal-title":"Blood."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1182\/bloodadvances.2017015578","article-title":"Differential antibacterial control by neutrophil subsets","volume":"2","author":"Leliefeld","year":"2018","journal-title":"Blood Adv."},{"key":"B37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI57990","article-title":"A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1","volume":"122","author":"Pillay","year":"2012","journal-title":"J Clin Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1172\/JCI124616","article-title":"More friend than foe: the emerging role of neutrophils in tissue repair","volume":"129","author":"Peiseler","year":"2019","journal-title":"J Clin Invest."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1182\/blood-2016-04-713206","article-title":"Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells","volume":"129","author":"Marini","year":"2017","journal-title":"Blood."},{"key":"B40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jaci.2005.02.002","article-title":"Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge","volume":"115","author":"Luijk","year":"2005","journal-title":"J Allergy Clin Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fmed.2017.00075","article-title":"Eosinophil activation status in separate compartments and association with asthma","volume":"4","author":"Johansson","year":"2017","journal-title":"Front Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e00085","DOI":"10.1128\/mBio.00085-21","article-title":"Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment","volume":"12","author":"Liu","year":"2021","journal-title":"MBio"},{"key":"B43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00441-017-2785-7","article-title":"Neutrophils in tissue injury and repair","volume":"371","author":"Wang","year":"2018","journal-title":"Cell Tissue Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","article-title":"Eosinophil responses during COVID-19 infections and coronavirus vaccination","volume":"146","author":"Lindsley","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"109798","DOI":"10.1016\/j.celrep.2021.109798","article-title":"Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19","volume":"37","author":"Kim","year":"2021","journal-title":"Cell Rep."}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2022.942699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T12:23:43Z","timestamp":1676204623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2022.942699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":45,"alternative-id":["10.3389\/falgy.2022.942699"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2022.942699","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/falgy.2022.942699.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/falgy.2022.942699.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/falgy.2022.942699.s003","asserted-by":"subject"}]},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"article-number":"942699"}}